Stability of the latent reservoir for HIV-1 in patients receiving valproic acid

Research output: Contribution to journalArticlepeer-review

Abstract

In light of a recent report that short-term treatment with valproic acid (VA) might accelerate the decay of the latent reservoir for HIV-1 in patients receiving combination therapy and allow eventual eradication of the infection, we studied patients with prolonged suppression of viremia who were receiving combination therapy and who had also been receiving chronic VA therapy for neurological or psychiatric conditions. Latently infected cells were readily detected in all patients at levels comparable to those seen in patients receiving combination therapy alone. We conclude that the clinical use of VA has no ancillary effect on the decay of the latent reservoir.

Original languageEnglish (US)
Pages (from-to)833-836
Number of pages4
JournalJournal of Infectious Diseases
Volume195
Issue number6
DOIs
StatePublished - Mar 15 2007

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Stability of the latent reservoir for HIV-1 in patients receiving valproic acid'. Together they form a unique fingerprint.

Cite this